School of Medicine


Showing 1-100 of 933 Results

  • Alistair Aaronson, MD

    Alistair Aaronson, MD

    Adjunct Clinical Assistant Professor, Medicine

    Bio Courses Taught through SHIELD (Stanford Healthcare Innovations and Experiential Learning Directive):
    A Patient Centered Exploration of Health and the Health Care System
    INDE 290B, INDE 290C, PAS 280B, PAS 280C

    This elective course for first year medical students explores challenges that patients face regarding the management of optimal health in a complex health care system. Specific topics include national healthcare reform, health economics and financing, social determinants of health, medication reconciliation, transitions of care, and the hospital discharge process.

  • Fahim Abbasi

    Fahim Abbasi

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Bio Dr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.

  • Oscar J. Abilez

    Oscar J. Abilez

    Instructor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Abilez' interests are aimed at elucidating how various biophysical and biochemical perturbations regulate early cardiovascular development across time and length scales that span several orders of magnitude, using human pluripotent stem cells as a model system.

  • Ranjana Advani

    Ranjana Advani

    Saul A. Rosenberg, MD, Professor of Lymphoma

    Current Research and Scholarly Interests Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.

    The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

  • Aijaz Ahmed

    Aijaz Ahmed

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

    Bio My research interests include nonalcoholic fatty liver disease (NAFLD) and viral hepatitis. I have focused my research to database analysis/outcomes and translational research in these areas. While database analysis has been critical in outlining trends in NAFLD and viral hepatitis epidemiology, translational research has provided insight into disease mechanism and future therapies. I collaborate with several basic science colleagues and act as clinical mentor for young investigators involved in translational research. I am also interested and act as adjunct faculty in biodesign and health policy. I have participated in several clinical trials as a co-investigator.

  • Neera Ahuja

    Neera Ahuja

    Clinical Professor, Medicine

    Current Research and Scholarly Interests Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system

  • Kevin Michael Alexander

    Kevin Michael Alexander

    Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center

    Bio Dr. Alexander is an advanced heart failure and transplant cardiologist at Stanford. He is also a member of the Stanford Amyloid Center and Stanford Cardiovascular Institute. He completed his internal medicine residency training at Johns Hopkins Hospital and cardiology fellowship at Brigham and Women’s Hospital/Harvard Medical School. He then finished his training in advanced heart failure and transplant cardiology at Stanford Hospital.

    He cares for patients in the clinic and in the hospital with advanced heart failure or those who underwent heart transplantation or mechanical circulatory support. His primary clinical and research interests lie in cardiac amyloidosis, in particular unraveling the molecular determinants of transthyretin amyloid cardiomyopathy to improve the diagnosis and treatment of this disease.

  • Ash A. Alizadeh, MD/PhD

    Ash A. Alizadeh, MD/PhD

    Associate Professor of Medicine (Oncology)

    Current Research and Scholarly Interests My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

    Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

  • Russ B. Altman

    Russ B. Altman

    Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine (General Medical Discipline), of Biomedical Data Science and, by courtesy, of Computer Science

    Current Research and Scholarly Interests I refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/

  • Myriam Amsallem, MD PhD

    Myriam Amsallem, MD PhD

    Instructor, Medicine - Cardiovascular Medicine

    Bio Myriam Amsallem MD PhD is a cardiologist specialized in cardiac imaging. Co-director of the RV analytics group at Stanford and Associate Director of the Clinical Biomarker and Phenotype Core Laboratory (Stanford Cardiovascular Institute), she has an interest in heart failure, cardio immunology and early detection of pulmonary hypertension using imaging, circulating biomarkers and digital health. She is currently working on developing novel noninvasive strategies to detect pulmonary hypertension and heart failure, including deep learning analysis of Doppler signals and 4D flow MRI. She also leads several educational projects to improve the quality of imaging methodology.

  • Shuchi Anand

    Shuchi Anand

    Assistant Professor of Medicine (Nephrology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Management of CKD and ESRD in low-resource settings
    Tubulointerstitial disease
    Chronic kidney disease of unknown etiology
    ESRD and physical activity
    ESRD and vitamin D deficiency

  • Chad Anderson

    Chad Anderson

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Chad Anderson is a Physician Assistant at Stanford ValleyCare and a Clinical Assistant Professor with the Stanford School of Medicine MSPA program. He is the Assistant Director of PA education at ValleyCare. He is dual credentialed as a Family Nurse Practitioner and a Physician Assistant. He completed his FNP/PA training at the Stanford School of Medicine and his graduate studies at A.T. Still University – Arizona School of Health Sciences. He has great interest in improving patient care through process improvement and has been the lead in many successful projects. He is passionate about improving our patients hospital experience as well as educating our future providers. He is also interested in Pre-Hospital Care and Emergency Medicine.

  • Jason Andrews

    Jason Andrews

    Associate Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests Our laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.

  • Justin P. Annes M.D., Ph.D.

    Justin P. Annes M.D., Ph.D.

    Associate Professor of Medicine (Endocrinology)

    Current Research and Scholarly Interests The ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders

    DIABETES
    The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.

    (1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.

    (2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.

    HEREDIATY PARAGAGLIOMA SYNDROME
    The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.

    As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families.

  • Sally Arai

    Sally Arai

    Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

    Current Research and Scholarly Interests Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.

  • Danit Ariel

    Danit Ariel

    Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Bio Danit Ariel, MD MS, is double board certified in Internal Medicine and Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.

    Dr. Ariel practices general endocrinology, with a special interest in thyroid disorders, menopause, LGBTQ+ health, and transgender medicine amongst others.

    She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.

    Dr. Ariel is passionate about medical education and teaching, and serves on the teaching faculty in the Stanford University School of Medicine. She completed an honors certificate in medical education from Stanford. She is the Founding Director of the Student Guidance Program for medical students. Finally, within the division of Endocrinology, she is the Director of Faculty Wellness.

    Appointments with with Dr. Ariel are available in the Hoover Pavilion on 211 Quarry Road.

  • Anna Chen Arroyo, MD, MPH

    Anna Chen Arroyo, MD, MPH

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Bio Dr. Arroyo specializes in the treatment of allergic conditions including drug allergy and asthma. She has a special interest in understanding health and healthcare disparities in allergic diseases and how allergies change over a person's lifetime.

  • Steven Artandi

    Steven Artandi

    Director, Stanford Cancer Institute, Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry

    Current Research and Scholarly Interests Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

  • Steven Asch

    Steven Asch

    Professor of Medicine (Primary Care and Population Health)

    Current Research and Scholarly Interests Describe your current research interest and activities

  • Euan A. Ashley

    Euan A. Ashley

    Associate Dean, School of Medicine, Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Rebecca Aslakson

    Rebecca Aslakson

    Associate Professor of Medicine (Primary Care and Population Health) and of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center

    Bio Dr. Rebecca A. Aslakson is an Associate Professor at Stanford University with appointments in both the Department of Primary Care & Population Health in the Palliative Care Section and the Department of Anesthesiology, Perioperative and Pain Medicine where she serves as Division Chief of Critical Care Anesthesia. With a Summa Cum Laude B.A. from Washington University in St. Louis, an MD from Harvard Medical School–MIT, and an MSci degree with Distinction from the University of Ulster in Northern Ireland, Dr. Aslakson completed anesthesia residency at Massachusetts General Hospital and surgical critical care fellowship at The Johns Hopkins Hospital, where she was on faculty from 2008-2017. In 2013, Dr. Aslakson obtained her PhD in Clinical Investigations from The Johns Hopkins Bloomberg School of Public Health with her dissertation concerning integration of palliative care in intensive care units. Triple boarded in anesthesia, surgical critical care, and palliative medicine, Dr. Aslakson is an active researcher and clinician; her goal is to improve delivery of effective and equitable palliative care, particularly to perioperative and critically ill populations. She has published over 80 peer-reviewed papers, invited editorials, and book chapters and received competitive funding from funders such as AHRQ, PCORI, the Foundation for Anesthesia Education and Research, and the National Palliative Care Research Society. Dr. Aslakson serves on national committees for professional societies including the American Academy of Hospice and Palliative Medicine (AAHPM), the American Society of Anesthesiologists (ASA), and the Society of Critical Care Medicine (SCCM). Dr. Aslakson has received national awards including the 2015 AAHPM Early Career Investigator Award and the 2014 ASA Presidential Scholar Award. Dr. Aslakson clinically attends at the Stanford University Medical Center in the M4 and E2 Intensive Care Units and on the inpatient palliative care clinical service. She lives in Palo Alto, CA with her husband and two sons.

  • Themistocles (Tim) Assimes

    Themistocles (Tim) Assimes

    Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests Genetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes

  • Mehrdad Ayati

    Mehrdad Ayati

    Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Dr. Ayati completed his residency at UC Davis and his fellowship at Stanford University. During his residency at UC Davis, Dr. Ayati received the Award of Excellence in Clinical Teaching. Dr. Ayati worked at hospitals such as Lodi Memorial Hospital in Lodi, California, and as an Emergency Medicine Attending at Veteran Affairs in Palo Alto, California. Dr. Ayati worked as a Stanford Medical Director at Los Altos and Palo Alto Subacute and Rehabilitation centers and he is currently serving as a medical advisor for many Skilled Nursing facilities and also memory care units and assisted living facilities in Northen California. Dr. Ayati has a broad spectrum of practice and knowledge of general medicine and primary care in various settings, from office to Emergency room and acute and Sub-acute care. Dr. Ayati’s main areas of research and clinical focus are in the physiology of aging and on finding practical and yet innovative ways of addressing the wellbeing and needs of the population in any age category. Dr. Ayati is an advocate of his patient’s physical and mental health at any age in addition to disease management and prevention. Dr. Ayati is currently a member of the Ethnogeriatric and Quality and Policy Performance Committees of the Americal Geraitric Society. He also serves as a Community Health Advisor for Alzheimer Association, Northen California and Nevada Chapter. Dr. Ayati is the author of “Paths to Healthy Aging”. Dr. Ayati is also a guest educational speaker on several radio stations such as National Public Radio (NPR) and San Francisco’s KQED and international and national conferences. He also testified in the Senate of the US, Special Committee of Aging in 2018 to address the challenges of aging populations in the US.
    Dr. Ayati strives to provide reliable information, effective strategies, and simple guidelines for patients of all ages to avoid or manage chronic diseases and to have a significantly better quality of life.
    Dr. Ayati’s main focus and passion are in:
    Raising awareness about Over Medication and Drug Cascade issues in the elderly population as well as highlighting prevention strategies
    Helping patients better understand and voice their end of life care choices and medical intervention wishes
    Bringing into focus the numerous social, economical, political and health challenges and hardship the elderly face in our society as well as finding solutions to address their needs
    Being the voice of the elderly in finding innovative and yet practical solutions to promote their physical and mental health and well being

  • Nitish Badhwar

    Nitish Badhwar

    Clinical Professor, Medicine - Cardiovascular Medicine

    Bio Nitish Badhwar, MD is Professor of Medicine and Director of Cardiac Electrophysiology Training Program at Stanford University School of Medicine. Dr. Badhwar received his medical degree from Maulana Azad Medical College (University of Delhi, India). After completing his internal medicine training from New York Hospital of Queens (affiliated with Cornell Medical School), he worked as faculty in the Department of Medicine at Hospital of St. Raphael (Yale University School of Medicine). He completed Cardiac Electrophysiology training at UCSF with Dr. Scheinman. After being on faculty at UCSF for 15 years he recently joined the Arrhythmia Service at Stanford Hospital. He is a Fellow of American College of Cardiology and Heart Rhythm Society. He has been named best doctor in cardiac electrophysiology in San Francisco Magazine 3 years in a row (2015-2017). This is nominated by his peers. He was given Excellence in Teaching award in Medical Education by Academy of Medical Educators in 2015. He was an invited speaker at prestigious international meetings including Oriental Congress of Cardiology (OCC) in Shanghai, China; Cardiostim EHRA /Europace in Nice, France; Asia Pacific Heart Rhythm Society (APHRS) in Seoul, S Korea; American Heart Association Annual Scientific Session in New Orleans, LA and Indian Heart Rhythm Society in New Delhi, India.


    Clinical Interest: Dr. Badhwar's clinical interest is in complex catheter ablation procedures including mapping and ventricular tachycardia (VT), atrial fibrillation (AF) and supraventricular tachycardia (SVT) including junctional variants of SVT. He started the epicardial ablation program at UCSF and also worked with Dr. Randall Lee to perform the first percutaneous epicardial left atrial appendage (LAA) ligation in the Bay Area in patients with atrial fibrillation. He has also differentiated himself in the field of electrophysiology by performing hybrid procedures with CT surgeons in patients with AF and VT. He is also involved in device implantation including pacemakers, ICD and biventricular pacing for heart failure.

    Research Interest: Dr. Badhwar has published electrophysiologic characteristics of SVTs including atrial tachycardia arising from the coronary sinus musculature, para-hisian atrial tachycardia, left sided AVNRT, junctional tachycardia and nodofascicular tachycardia. He has also published on the use of nuclear medicine (ERNA) in assessing left ventricular dyssynchrony as well as optimal pacing sties in patients with heart failure requiring biventricular pacing. He has described the unique clinical characteristics of epicardial idiopathic VT arising from the cardiac crux. He has also published clinical outcomes of combining LAA ligation with catheter ablation of atrial fibrillation perform (first in human percutaneous closed chested Maze procedure) and is now part of a multi-center randomized study comparing standard ablation to ablation plus LAA ligation in patients with persistent atrial fibrillation (aMAZE trial).

  • Matthew Baker

    Matthew Baker

    Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    Bio Dr. Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials and bench-to-bedside translational research. He has designed and led investigator-initiated studies with a focus on sarcoidosis, Sjogren’s syndrome, and IgG4-related disease. In addition, he is a founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program and collaborates with other team members to advance sarcoidosis clinical care and research.

  • Niaz Banaei

    Niaz Banaei

    Professor of Pathology and of Medicine (Infectious Diseases) at the Stanford University Medical Center

    Current Research and Scholarly Interests His research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.

  • Subhas Banerjee

    Subhas Banerjee

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Banerjee is the Director of Endoscopy at the Stanford University Medical Center. His research interests include evaluation of advanced endoscopic procedures (ERCP, choledochoscopy and endoscopic ultrasound) in the diagnosis and management of benign and malignant pancreatic and biliary disease. Additional interests include the development of new endoscopic devices and instruments.

  • Michele Barry, MD, FACP

    Michele Barry, MD, FACP

    Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine & Senior Fellow at the Woods Institute and at the Freeman Spogli Institute

    Current Research and Scholarly Interests Areas of research
    Ethical Aspects of research conducted overseas
    Clinical Tropical Diseases
    Globalization's Impact upon Health Disparities
    Hemorrhagic Viruses

  • Preetha Basaviah, M.D.

    Preetha Basaviah, M.D.

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Medical education, preparation for clerkship curricula and hospital medicine.

  • Marina Basina

    Marina Basina

    Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Current Research and Scholarly Interests Diabetes type I and type II, insulin pump therapy, glucose sensor technology, insulin resistance, PCOS, thyroid disorders

  • Tina Baykaner

    Tina Baykaner

    Instructor, Medicine - Cardiovascular Medicine

    Bio Tina Baykaner is an Instructor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency, cardiovascular medicine and advanced heart failure fellowship trainings at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. She has published over 200 papers, book chapters and abstracts including over 50 original peer-reviewed articles, and delivered over 20 invited presentations in national and international meetings. She serves as section editor and editorial board member of four electrophysiology journals.

    Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society. Dr. Baykaner's clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inapproriate sinus tachycardia management, device implantation and device extraction.

    Dr. Baykaner is an active member of American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC). She serves as an elected member of the Communications Committee for HRS, and previously served as an elected member of the ACC Task Force ICD research committee. She also served in the Organizing Committee for Stanford Cardiovascular Institute Annual Postdoctoral Research Meeting in 2017 and 2018 and for Early Career related sessions for HRS Scientific Sessions in 2019 and 2020.

  • Laren Becker

    Laren Becker

    Clinical Instructor, Medicine - Gastroenterology & Hepatology

    Bio I am a physician-scientist in the Division of Gastroenterology at Stanford University. My clinical and research interest has been in neurogastroenterology. Specifically, my research has been exploring the interplay between immune cells and the enteric nervous system, and evaluating how perturbations of this interaction as a result of aging disrupts gastrointestinal neuromuscular function. Ultimately, my hope is that insights from this research provide novel therapies for treating patients with motility disorders like constipation and irritable bowel syndrome.

  • Harmeet Bedi

    Harmeet Bedi

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Bio Harmeet Bedi is an Interventional Pulmonologist and Clinical Assistant Professor at Stanford University Medical Center and School of Medicine. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign and malignant airway obstruction, asthma, and pleural diseases. He has specific training in rigid bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS) and electromagnetic navigation bronchoscopy, bronchial thermoplasty, intrabronchial valve (IBV) insertion, pleural catheter insertion, and medical thoracoscopy. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, photodynamic therapy (PDT), and cryotherapy.

  • Eran Bendavid

    Eran Bendavid

    Associate Professor of Medicine (Primary Care and Population Health), Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Health Research and Policy

    Current Research and Scholarly Interests Effect of global health policies on health of individuals in developing countries, global health, HIV and TB.

  • Vivek Bhalla, MD

    Vivek Bhalla, MD

    Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.

  • Ankur Bharija

    Ankur Bharija

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Personal and Professional (Clinical, research, and teaching) interests include promoting health and wellbeing for the frail elders and the seriously ill -- through innovation in High-value healthcare delivery systems, Public health-education, Health Information-technology and Social entrepreneurship.

  • Ami Bhatt

    Ami Bhatt

    Assistant Professor of Medicine (Hematology) and of Genetics

    Current Research and Scholarly Interests The Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.

  • Jayanta Bhattacharya

    Jayanta Bhattacharya

    Professor of Medicine, Senior Fellow at the Stanford Institute for Economic Policy Research and, by courtesy, at the Freeman Spogli Institute and Professor, by courtesy, of Health Research and Policy and of Economics

    Current Research and Scholarly Interests My research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.

  • Brian Blackburn

    Brian Blackburn

    Clinical Associate Professor, Medicine - Infectious Diseases

    Current Research and Scholarly Interests My interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya

  • Terrence Blaschke

    Terrence Blaschke

    Professor of Medicine and of Molecular Pharmacology, Emeritus

    Current Research and Scholarly Interests Clinical pharmacology of antiretroviral drugs

    Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.

    Drug development

  • Douglas W. Blayney

    Douglas W. Blayney

    Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Improving the quality of cancer care at Stanford, in our network of care, and nationally

  • Catherine Blish

    Catherine Blish

    Associate Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly Interests The major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.

  • Gordon Bloom

    Gordon Bloom

    Lecturer, Medicine - Primary Care and Population Health

    Bio Gordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social ventures in global health and environmental sustainability.

    At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, an affiliate at the Center for Health Policy and the Center for Primary Care and Outcomes Research, Freeman Spogli Institute for International Studies, and a mentor in the Knight-Hennessy Scholars Program.

    At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.

    At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the Woodrow Wilson School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.

    At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.

    Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.

    Gordon is an author in the edited volume Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Yunus, Drayton et. al., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company and in international strategy consulting.

    Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey (21) and son Jason (17), and live in the residential section of campus.

  • Paul Bollyky

    Paul Bollyky

    Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly Interests We are a translational immunology lab in the Division of Infectious Diseases at Stanford University.

  • Hector Fabio Bonilla

    Hector Fabio Bonilla

    Clinical Associate Professor, Medicine - Infectious Diseases

    Bio As a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.

  • Linda Boxer, MD, PhD

    Linda Boxer, MD, PhD

    Vice Dean of the School of Medicine and Stanley McCormick Memorial Professor in the School of Medicine

    Current Research and Scholarly Interests Regulation of expression of oncogenes in normal and malignant hematologic cells.

  • Christina Bradshaw

    Christina Bradshaw

    Clinical Instructor, Medicine - Nephrology

    Current Research and Scholarly Interests Dr. Bradshaw is interested in studying counseling practices and transitions of care among persons with advanced chronic kidney disease and end-stage renal disease in low- and middle-income countries.

  • Margaret Brandeau

    Margaret Brandeau

    Coleman F. Fung Professor in the School of Engineering and Professor, by courtesy, of Medicine (PCOR)

    Bio Professor Brandeau is the Coleman F. Fung Professor in the School of Engineering and a Professor of Medicine (by Courtesy). Her research focuses on the development of applied mathematical and economic models to support health policy decisions. Her recent work has focused on HIV prevention and treatment programs, programs to control the spread of hepatitis B virus, and public health preparedness plans. She has served as Principal Investigator or Co-PI on a broad range of funded research projects.

    She is a Fellow of the Institute for Operations Research and Management Science (INFORMS) and a member of the Omega Rho International Honor Society for Operations Research and Management Science. From INFORMS she has received the President’s Award (recognizing important contributions to the welfare of society), the Pierskalla Prize (in 2001 and 2017, for research excellence in health care management science), the Philip McCord Morse Lectureship Award, and the Award for the Advancement of Women in Operations Research and the Management Sciences. She has also received the Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research from the International Society for Pharmacoeconomics and Outcomes Research, and a Presidential Young Investigator Award from the National Science Foundation, among other awards. Professor Brandeau earned a BS in Mathematics and an MS in Operations Research from MIT, and a PhD in Engineering-Economic Systems from Stanford.

  • Rondeep Brar

    Rondeep Brar

    Clinical Associate Professor, Medicine - Hematology

    Bio I aim to provide high quality care in a diverse patient practice. My clinic includes all types of hematologic disorders, ranging from anemia, clotting/bleeding disorders, and low blood counts to complex malignancies such as leukemia, myelodysplastic syndrome, myeloma, and lymphoma.

    My research interests include the advancement of personalized genomic medicine and the development of targeted therapeutics for cancer therapy.

    My goal is to combine the efficiency of a private office with the complex care expected of a tertiary institution like Stanford. I value your time and strive to maintain an on-schedule clinic.

  • Keri Brenner

    Keri Brenner

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Keri Brenner, MD, MPA is a palliative care physician and a psychiatrist. Her clinical work includes inpatient palliative care consults and psychotherapy for palliative care patients at Stanford. Dr. Brenner’s scholarly interests and research focus on psychodynamic and existential issues in patients with serious illness. Dr. Brenner completed her medical degree at Yale School of Medicine, where she received honors for her thesis on the phenomenology of suffering with terminal illness. She also has a Master in Public Administration from Harvard’s Kennedy School. Dr. Brenner trained in adult psychiatry residency at Massachusetts General Hospital / McLean and palliative care fellowship at Harvard.

  • Wes (Janice) Brown

    Wes (Janice) Brown

    Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

    Bio Dr. Janice (Wes) Brown specializes in the treatment of infectious complications that occur in patients who are receiving cancer treatments or are undergoing transplantation of solid organs or hematopoietic cells. She has been a member of the Blood and Marrow Transplantation faculty for more than twenty years and co-founded the Immunocompromised Host Infectious Diseases consultation service. Dr. Brown’s special interest is to understand the nature of immunodeficiency resulting from an ever- evolving spectrum of targeted and immunomodulatory therapy. Her laboratory studies approaches to enhance and/or rebuild protective immunity. She is a leader in the design and execution of clinical trials of new treatments for infections that have significantly improved the outcomes of high-risk patients.

  • Nam Quoc Bui

    Nam Quoc Bui

    Clinical Assistant Professor, Medicine - Oncology

    Bio Dr. Bui is a Clinical Assistant Professor of Medicine at the Stanford Cancer Institute and a specialist in the Sarcoma and Developmental Therapeutics programs. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data. His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies.

  • Nicole Burwell

    Nicole Burwell

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Bio Dr. Burwell is a Clinical Associate Professor in the Department of Medicine, Division of Primary Care. She currently serves as the Director of Pre-Clerkship Education for the Stanford School of Medicine, Master of Science in PA Studies program. Dr. Burwell previously served as a member of the PA program leadership team at George Washington University for more than 8 years. Dr. Burwell is a seasoned clinical PA with almost twenty years of experience in Internal Medicine and Occupational Health. She completed her PA training at George Washington University where she earned a MSHS. She also holds a Ph.D. from Howard University School of Pharmacy and Allied Health. Her research interests include Health Disparities and Nutritional Sciences with a focus on the pivotal role it plays in cardiovascular disease.

  • Robert W. Carlson

    Robert W. Carlson

    Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Clinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.

Latest information on COVID-19